Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$323.37(as of Apr 10, 3:35 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$323.37
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,500
CountyUSA
Market Cap$43,400.9M
EBIDTA557.2M
10-Day Moving Average323.85
P/E Ratio139.55
20-Day Moving Average319.50
Forward P/E Ratio36.10
50-Day Moving Average325.76
Earnings per Share2.32
200-Day Moving Average393.51
Profit Margin16.99%
RSI48.58
Shares Outstanding132.6M
ATR11.70
52-Week High495.55
Volume1,021,712
52-Week Low220.54
Book Value789.2M
P/B Ratio55.48
Upper Keltner345.81
P/S Ratio11.79
Lower Keltner293.18
Debt-to-Equity Ratio345.81
Next Earnings DateUnknown
Cash Surplus190.9M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of Apr 10, 2026
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.